275 related articles for article (PubMed ID: 23986411)
1. The care and management of bisphosphonate--associated osteonecrosis of the jaw in the patient with multiple myeloma: a case study.
Teah MJ; Syme SL; Scheper M; Weikel DS
J Dent Hyg; 2013 Aug; 87(4):181-7. PubMed ID: 23986411
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-related osteonecrosis of the jaws--a case report.
Kamoh AK; Ogle O
Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
[TBL] [Abstract][Full Text] [Related]
3. [Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma].
Lund T; Gregersen H; Vangsted A; Marker P; Abildgaard N
Ugeskr Laeger; 2009 Jan; 171(1-2):50-2. PubMed ID: 19128568
[TBL] [Abstract][Full Text] [Related]
4. Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma.
Jarnbring F; Kashani A; Björk A; Hoffman T; Krawiec K; Ljungman P; Lund B
Br J Oral Maxillofac Surg; 2015 Dec; 53(10):1007-11. PubMed ID: 26530732
[TBL] [Abstract][Full Text] [Related]
5. [Bisphosphonate-related osteonecrosis of the jaw].
Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
[TBL] [Abstract][Full Text] [Related]
6. [Bisphosphonate related osteonecrosis of the jaws: a case report and review of the literature].
Ye WC; Li Y; Zhang B
Shanghai Kou Qiang Yi Xue; 2012 Jun; 21(3):354-8. PubMed ID: 22885505
[TBL] [Abstract][Full Text] [Related]
7. [Bisphosphonate-related osteonecrosis of the jaw complicated with wrist scaphoid osteomyelitis: a case report].
Sun ZW; Li ZY; Yu D; Zhu JY; Zhang YD; Zhu XM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Apr; 37(2):224-228. PubMed ID: 31168992
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate complications including osteonecrosis of the jaw.
Mehrotra B; Ruggiero S
Hematology Am Soc Hematol Educ Program; 2006; ():356-60, 515. PubMed ID: 17124083
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
Guo Y; Wang D; An J; Peng X; Cai Z; Guo C
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210
[TBL] [Abstract][Full Text] [Related]
11. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
Janovska Z; Mottl R; Slezak R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
[TBL] [Abstract][Full Text] [Related]
12. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
13. Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.
Lobato JV; Maurício AC; Rodrigues JM; Cavaleiro MV; Cortez PP; Xavier L; Botelho C; Hussain NS; Santos JD
J Plast Reconstr Aesthet Surg; 2008; 61(1):99-106. PubMed ID: 18068658
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
Migliorati CA; Siegel MA; Elting LS
Lancet Oncol; 2006 Jun; 7(6):508-14. PubMed ID: 16750501
[TBL] [Abstract][Full Text] [Related]
16. Removal of a sequestrum by a patient with medication-related osteonecrosis of the jaw.
Davies M; Power A; Kanatas A
Br J Oral Maxillofac Surg; 2017 Nov; 55(9):980-981. PubMed ID: 28964667
[No Abstract] [Full Text] [Related]
17. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
Edwards BJ; Gounder M; McKoy JM; Boyd I; Farrugia M; Migliorati C; Marx R; Ruggiero S; Dimopoulos M; Raisch DW; Singhal S; Carson K; Obadina E; Trifilio S; West D; Mehta J; Bennett CL
Lancet Oncol; 2008 Dec; 9(12):1166-72. PubMed ID: 19038763
[TBL] [Abstract][Full Text] [Related]
18. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates.
Pavkovic M; Petrushevska G; Jovanovic R; Karanfilski O; Cevreska L; Stankovic S; Stojanovic A
Prilozi; 2010; 31(2):39-49. PubMed ID: 21258276
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases.
Tam Y; Kar K; Nowzari H; Cha HS; Ahn KM
Clin Implant Dent Relat Res; 2014 Oct; 16(5):751-61. PubMed ID: 23445465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
